Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia
PRFM-1
1 other identifier
interventional
107
1 country
1
Brief Summary
Dysfunctional chronic diffuse pain syndrome, concerning 2% of the French population, Fibromyalgia (FM) is classified either as a psychological disease or as a somatic disease. This dichotomous reasoning does not lead to a better understanding and does not allow the use or development of new psychological tools of care. The issue of the proximity between FM and depression highlighted by some authors and the presence of anxious comorbidities may arise at a different level, that of the transdiagnostic approach. Rumination is one of these transdiagnostic processes that are the subject of recent studies and one of the dimensions of which (abstract analytical rumination) is at work in depression and a number of psychopathologies. The investigator therefore wishes to explore the process of rumination and its abstract analytical dimension in FM and to explore its link with the depressive and anxious manifestations frequently associated with this disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2015
CompletedFirst Submitted
Initial submission to the registry
April 4, 2017
CompletedFirst Posted
Study publicly available on registry
April 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 26, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 26, 2017
CompletedSeptember 19, 2025
September 1, 2025
2.2 years
April 4, 2017
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire
Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire
1 hour
Study Arms (1)
Patient with Fibromyalgia
OTHERInterventions
Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.
Eligibility Criteria
You may qualify if:
- FM Criteria of the American College of Rheumatology ACR 1990.
- Major Patients
- free and informed consent signed
- stable treatment for at least one month
- Native French speaker
- Patient covered by health insurance.
You may not qualify if:
- Patient deprived of liberty or protected major (under guardianship or curatorship)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens Picardie
Amiens, Picardie, 80054, France
Related Publications (1)
Fonseca Das Neves J, Serra E, Kosinski T, Marechal V, Rollin N, Richard O, Jehel L, Rusinek S. Catastrophizing and rumination mediate the link between functional disabilities and anxiety/depression in fibromyalgia. A double-mediation model. Encephale. 2024 Apr;50(2):162-169. doi: 10.1016/j.encep.2023.04.004. Epub 2023 May 1.
PMID: 37137739RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2017
First Posted
April 28, 2017
Study Start
September 16, 2015
Primary Completion
November 26, 2017
Study Completion
November 26, 2017
Last Updated
September 19, 2025
Record last verified: 2025-09